
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Kaishore Guggulu is an Ayurvedic herbal formulation containing guggulsterones that reduce inflammation by inhibiting pro-inflammatory cytokines like TNF-α and IL-1β. The compound supports liver detoxification through enhanced glutathione production and bile acid synthesis.

Reported Benefits (Provisional)
Origin & History

Kaishore Guggulu is a traditional Ayurvedic formulation that combines several herbs, including Guggulu, to support skin health and detoxification. It is prepared by blending these herbs into a fine powder and forming tablets.
Research Narrative (Provisional)
There is limited scientific research specifically on Kaishore Guggulu. However, individual components like Guggulu have been studied for their anti-inflammatory properties in randomized controlled trials.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Kaishore Guggulu is a traditional Ayurvedic polyherbal-mineral formulation, not a food, so standard macronutrient profiling (carbohydrates, fats, protein) is not directly applicable at typical dosage (250–500 mg tablets, 1–2 tablets twice daily). Key bioactive compounds and constituents include: Guggulsterones (Z- and E-isomers): approximately 2.5–5% w/w of guggul resin (Commiphora mukul); primary anti-inflammatory and hypolipidemic actives; moderate oral bioavailability (~40–50%) enhanced by co-formulated piperine from Piper longum. Curcuminoids (from Haridra/Curcuma longa): approximately 2–5% curcumin content in the turmeric ingredient; anti-inflammatory and antioxidant; inherently low bioavailability (~1–2%) but improved by piperine (up to 2000% enhancement). Piperine (from Pippali/Piper longum and Maricha/Piper nigrum): approximately 3–9% in pepper ingredients; serves as bioenhancer for curcumin and guggulsterones. Gallic acid and ellagic acid (from Triphala components – Amalaki, Bibhitaki, Haritaki): Amalaki contributes significant Vitamin C (~300–600 mg per 100 g of amla fruit powder); ellagitannins ~1–2% w/w; chebulagic acid and chebulinic acid from Haritaki ~2–4% w/w. Berberine and related alkaloids (from Daruharidra/Berberis aristata): approximately 2–5% berberine content; bioavailability ~5% orally; exhibits antimicrobial and hepatoprotective activity. Giloy/Guduchi (Tinospora cordifolia): contains tinosporin, berberine, palmatine, and polysaccharides (arabinogalactan); immunomodulatory diterpenoids ~0.5–1%. Mineral content: trace iron, calcium, and zinc contributed by herbal ash and guggul resin; iron ~0.5–2 mg per gram of formulation depending on manufacturer. Gum resin components: myrrhanone, myrrhanol, and mukulol from guggul resin providing additional anti-arthritic activity. Fiber: negligible at therapeutic doses (~1–2 g/day total intake). Calories: negligible (<5 kcal per daily dose). Note on bioavailability: The polyherbal synergy, particularly the inclusion of piperine-containing herbs, is traditionally designed to enhance the absorption of otherwise poorly bioavailable compounds like curcumin and guggulsterones. The triphala component may also enhance gut absorption through its mild laxative and prebiotic effects on intestinal mucosa.
Reported Mechanism (Provisional)
Kaishore Guggulu's guggulsterones inhibit nuclear factor-kappa B (NF-κB) pathway, reducing production of inflammatory cytokines TNF-α, IL-1β, and IL-6. The formulation enhances liver phase II detoxification by upregulating glutathione S-transferase enzymes. Triphala components stimulate digestive enzymes and promote bile acid synthesis through cholesterol 7α-hydroxylase activation.
Clinical Narrative (Provisional)
Limited clinical research exists specifically on Kaishore Guggulu as a complete formulation. Individual component studies show guggul extract reduced joint pain in 30 rheumatoid arthritis patients by 25% over 6 months. Small pilot studies (n=20-40) suggest benefits for skin conditions and liver function markers, but larger randomized controlled trials are needed. Most evidence comes from traditional use and animal studies rather than robust human clinical data.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







